InvestorLens

VRTX — VERTEX PHARMACEUTICALS INC

Health Care · Biotechnology

Sign in to save5 tracked investors reported this
For educational research only.InvestorLens analyzes public regulatory filings (SEC EDGAR, STOCK Act PTRs) that may be delayed by 45 days or more. Information shown is historical and is not financial, legal, or tax advice, nor a recommendation or solicitation to buy or sell any security. Always do your own research.

InvestorLens aggregates public filing data to show which tracked investors reported holdings in this stock. Dollar values represent reported position values, not market capitalization, and may be delayed up to 45 days. Not a recommendation.

Sourced from SEC EDGAR public filings

About VERTEX PHARMACEUTICALS INC (VRTX)

VERTEX PHARMACEUTICALS INC (VRTX) appears in the most recent 13F filings of 5 tracked institutional investors. VERTEX PHARMACEUTICALS INC is classified in the Health Care sector (Biotechnology industry). The largest disclosed position is held by Ken Griffin (Citadel Advisors), valued at $282M. Across recent filings, tracked investors recorded 2 new positions, 1 increased, 2 reduced, and 1 exited. All data sourced from SEC 13F filings.

Smart Money Consensus™

Based on recent institutional activity in VRTX

50
/100
Mixed Activity
Added / Increased3
Reduced2
Exited1
BearishBullish
Crowded Trade Score™

How many top investors track VRTX

33
/100
Emerging Interest
5investors

A small number of top investors own this.

UndiscoveredCrowded
151015+

VRTX Ownership Composition

How VERTEX PHARMACEUTICALS INC is held across tracked investor types, based on reported 13F positions.

Dominant Type
Other
98% of tracked value
Institutions
5
tracked investors
Total Reported
$378.4M
combined 13F value
Sectors3
  • Other97.6%
  • Hedge Funds2.4%
  • Growth Funds0.0%
Other(3)
97.6%
Hedge Funds(1)
2.4%
Growth Funds(1)
0.0%

Tracked investors reporting VRTX

  • Ken GriffinMar 31, 2026
    Citadel Advisors
    Shares
    631.5K
    Value
    $282M
    % Portfolio
    0.05%
  • Izzy EnglanderMar 31, 2026
    Millennium Management
    Shares
    182.3K
    Value
    $81.4M
    % Portfolio
    0.03%
  • Steve CohenMar 31, 2026
    Point72 Asset Management
    Shares
    20.2K
    Value
    $9M
    % Portfolio
    0.01%
  • Ray DalioMar 31, 2026
    Bridgewater Associates
    Shares
    13.4K
    Value
    $6M
    % Portfolio
    0.03%
  • Cathie WoodDec 31, 2025
    ARK Investment Management
    Shares
    26.1K
    Value
    $11.8K
    % Portfolio
    0.00%

Recent activity

Frequently asked questions

How many institutional investors hold VRTX?
5 tracked institutional investors disclosed a position in VRTX (VERTEX PHARMACEUTICALS INC) in their most recent 13F filing.
Who is the largest institutional holder of VRTX?
Ken Griffin, Citadel Advisors, holds the largest disclosed position in VRTX, valued at $282M.
Did institutional ownership of VRTX increase or decrease?
Across recent 13F filings, tracked investors recorded 2 new positions, 1 increased, 2 reduced, and 1 fully exited VRTX.
What sector is VRTX in?
VERTEX PHARMACEUTICALS INC is classified in the Health Care GICS sector, Biotechnology industry.
Where does this VRTX ownership data come from?
SEC Form 13F-HR filings, accessed via EDGAR. 13F filings are disclosed quarterly with a 45-day reporting delay and cover U.S.-listed long equity positions only. This is not investment advice.